[go: up one dir, main page]

SG10201913351XA - Compositions for rna-chromatin interaction analysis and uses thereof - Google Patents

Compositions for rna-chromatin interaction analysis and uses thereof

Info

Publication number
SG10201913351XA
SG10201913351XA SG10201913351XA SG10201913351XA SG10201913351XA SG 10201913351X A SG10201913351X A SG 10201913351XA SG 10201913351X A SG10201913351X A SG 10201913351XA SG 10201913351X A SG10201913351X A SG 10201913351XA SG 10201913351X A SG10201913351X A SG 10201913351XA
Authority
SG
Singapore
Prior art keywords
rna
compositions
interaction analysis
chromatin interaction
chromatin
Prior art date
Application number
SG10201913351XA
Inventor
Yijun Ruan
Meizhen Zheng
Junhong Luo
Original Assignee
Jackson Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jackson Lab filed Critical Jackson Lab
Publication of SG10201913351XA publication Critical patent/SG10201913351XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/101Crosslinking agents, e.g. psoralen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/207Modifications characterised by siRNA, miRNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/10Detection mode being characterised by the assay principle
    • C12Q2565/113Detection mode being characterised by the assay principle based on agglutination/precipitation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/10Detection mode being characterised by the assay principle
    • C12Q2565/133Detection mode being characterised by the assay principle conformational analysis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
SG10201913351XA 2013-09-05 2014-09-05 Compositions for rna-chromatin interaction analysis and uses thereof SG10201913351XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361873928P 2013-09-05 2013-09-05

Publications (1)

Publication Number Publication Date
SG10201913351XA true SG10201913351XA (en) 2020-03-30

Family

ID=51541390

Family Applications (4)

Application Number Title Priority Date Filing Date
SG10201913351XA SG10201913351XA (en) 2013-09-05 2014-09-05 Compositions for rna-chromatin interaction analysis and uses thereof
SG10201801779XA SG10201801779XA (en) 2013-09-05 2014-09-05 Compositions for rna-chromatin interaction analysis and uses thereof
SG10201913362PA SG10201913362PA (en) 2013-09-05 2014-09-05 Compositions for rna-chromatin interaction analysis and uses thereof
SG11201600645SA SG11201600645SA (en) 2013-09-05 2014-09-05 Compositions for rna-chromatin interaction analysis and uses thereof

Family Applications After (3)

Application Number Title Priority Date Filing Date
SG10201801779XA SG10201801779XA (en) 2013-09-05 2014-09-05 Compositions for rna-chromatin interaction analysis and uses thereof
SG10201913362PA SG10201913362PA (en) 2013-09-05 2014-09-05 Compositions for rna-chromatin interaction analysis and uses thereof
SG11201600645SA SG11201600645SA (en) 2013-09-05 2014-09-05 Compositions for rna-chromatin interaction analysis and uses thereof

Country Status (11)

Country Link
US (2) US9938565B2 (en)
EP (3) EP3299476B1 (en)
JP (2) JP6684216B2 (en)
KR (1) KR102310441B1 (en)
CN (2) CN111979229A (en)
AU (1) AU2014315104B2 (en)
CA (1) CA2936089A1 (en)
HK (2) HK1252806A1 (en)
IL (2) IL244191B (en)
SG (4) SG10201913351XA (en)
WO (1) WO2015035108A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11435358B2 (en) 2011-06-23 2022-09-06 Board Of Regents, The University Of Texas System Single molecule peptide sequencing
EP3299476B1 (en) * 2013-09-05 2023-07-19 The Jackson Laboratory Compositions for rna-chromatin interaction analysis and uses thereof
KR20170099739A (en) * 2016-02-23 2017-09-01 노을 주식회사 Contact-type staining-assist patch, manufacturing method thereof and staining method using the patch
CN109153698B (en) * 2016-04-27 2022-04-05 生物辐射实验室股份有限公司 miRNA transcriptome methods and compositions
CN106047861A (en) * 2016-06-07 2016-10-26 苏州贝斯派生物科技有限公司 Reagent capable of rapidly repairing damaged DNA as well as preparation method and application of reagent
CN109641933B (en) * 2016-09-02 2023-09-29 路德维格癌症研究有限公司 Genome-wide identification of chromatin interactions
EP4491740A3 (en) * 2016-09-02 2025-02-26 New England Biolabs, Inc. Analysis of chromatin using a nicking enzyme
CN107130021B (en) * 2017-05-04 2020-06-05 中昱医学检验(广州)有限公司 Application of CCAT1 long-chain non-coding RNA and small-molecule inhibitor thereof in hepatocellular carcinoma treatment
US20200123590A1 (en) * 2017-06-16 2020-04-23 The Jackson Laboratory Single nucleus and single molecule chromatin interaction assays
CN107488713A (en) * 2017-08-11 2017-12-19 华中科技大学同济医学院附属同济医院 Biotinylated chromatin co-immunoprecipitation method and kit
CN110551794B (en) * 2018-06-04 2023-05-30 完整基因有限公司 Method and kit for processing RNA molecules and complex
AU2019301750A1 (en) * 2018-07-12 2021-01-28 Board Of Regents, The University Of Texas System Molecular neighborhood detection by oligonucleotides
CN113015740A (en) 2018-10-05 2021-06-22 德克萨斯大学系统董事会 Solid phase N-terminal peptide capture and release
CA3134831A1 (en) 2019-04-05 2020-10-08 Claret Bioscience, Llc Methods and compositions for analyzing nucleic acid
EP4000014A4 (en) 2019-07-19 2023-09-20 The Jackson Laboratory CONVOLUTIONAL NEURAL NETWORKS FOR CLASSIFICATION OF HISTOLOGICAL IMAGES OF CANCER
CN114729351A (en) * 2019-11-15 2022-07-08 相位基因组公司 Chromosome conformation capture from tissue samples
CN113322254B (en) * 2021-01-06 2022-05-20 南京诺唯赞生物科技股份有限公司 Methods and tools for multi-target protein-DNA interaction
CN114438183B (en) * 2022-02-25 2024-08-20 南方科技大学 RNA-mediated chromatin conformation capture method
WO2025048512A1 (en) * 2023-08-30 2025-03-06 주식회사 제노헬릭스 Method for constructing rna library using restriction enzyme

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4766072A (en) 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
US5565340A (en) * 1995-01-27 1996-10-15 Clontech Laboratories, Inc. Method for suppressing DNA fragment amplification during PCR
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
ATE312942T1 (en) 2000-10-25 2005-12-15 Hoffmann La Roche AMPLIFICATION USING MODIFIED PRIMERS
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
ES2361739T3 (en) 2002-08-16 2011-06-21 Immunogen, Inc. RETICULANTS WITH HIGH REACTIVITY AND SOLUBILITY AND ITS USE IN THE PREPARATION OF CONJUGATES FOR THE DIRECTED SUPPLY OF DRUGS OF SMALL MOLECULE.
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
US8071296B2 (en) * 2006-03-13 2011-12-06 Agency For Science, Technology And Research Nucleic acid interaction analysis
HRP20140172T1 (en) 2006-05-30 2014-03-28 Genentech, Inc. ANTI-ANTIBODIES AND IMMUNOCONSULATES AS THEIR USES
US20080124707A1 (en) 2006-06-09 2008-05-29 Agency For Science, Technology And Research Nucleic acid concatenation
MX2010011808A (en) 2008-04-30 2011-03-04 Immunogen Inc Potent conjugates and hydrophilic linkers.
CN104524590B (en) 2008-04-30 2019-06-21 伊缪诺金公司 The purposes of crosslinking agent and they
EP2705156B1 (en) * 2011-05-05 2015-08-26 Institut National de la Santé et de la Recherche Médicale (INSERM) Linear dna amplification
EP3299476B1 (en) * 2013-09-05 2023-07-19 The Jackson Laboratory Compositions for rna-chromatin interaction analysis and uses thereof

Also Published As

Publication number Publication date
SG10201913362PA (en) 2020-03-30
US20160177380A1 (en) 2016-06-23
AU2014315104A1 (en) 2016-02-18
JP6684216B2 (en) 2020-04-22
JP2016532454A (en) 2016-10-20
CN111979229A (en) 2020-11-24
SG11201600645SA (en) 2016-03-30
KR102310441B1 (en) 2021-10-07
EP3041952A1 (en) 2016-07-13
EP3299476B1 (en) 2023-07-19
IL244191B (en) 2020-02-27
KR20160048992A (en) 2016-05-04
IL272171A (en) 2020-03-31
EP3299476A1 (en) 2018-03-28
AU2014315104B2 (en) 2020-11-05
EP3296408A1 (en) 2018-03-21
US9938565B2 (en) 2018-04-10
IL244191A0 (en) 2016-04-21
CN105899672B (en) 2020-09-11
EP3041952B1 (en) 2017-12-20
CN105899672A (en) 2016-08-24
IL272171B (en) 2020-10-29
HK1252807A1 (en) 2019-06-06
US11466307B2 (en) 2022-10-11
JP2020036598A (en) 2020-03-12
CA2936089A1 (en) 2015-03-12
SG10201801779XA (en) 2018-04-27
HK1252806A1 (en) 2019-06-06
WO2015035108A1 (en) 2015-03-12
US20180312908A1 (en) 2018-11-01

Similar Documents

Publication Publication Date Title
IL272171B (en) Compositions for rna-chromatin interaction analysis and uses thereof
IL273205A (en) Compositions and methods
GB2521022B (en) Compositions and methods
SMT201900635T1 (en) Compositions and methods for activating
IL244850A0 (en) Stabilized efinaconazole compositions and uses thereof
PL3065569T3 (en) Composition
GB201308072D0 (en) Compositions and methods
GB201321693D0 (en) Composition and uses thereof
EP3006525A4 (en) Asphalt-urethane composition
GB201318489D0 (en) Composition
GB201319540D0 (en) Composition
GB201317388D0 (en) Composition
GB201305813D0 (en) Compositions and methods
GB201320303D0 (en) Composition
GB201319538D0 (en) Composition
GB201306984D0 (en) Composition
GB201322456D0 (en) Radiotracer compositions and methods
EP2964610A4 (en) Vinylsulfone-based 18f-labeling compositions and methods and uses thereof
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
GB201320504D0 (en) Composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201318394D0 (en) Composition
GB201305622D0 (en) Composition